Showing 6781-6800 of 7110 for: Cochrane Systematic Reviews Back
- Treatments for suppression of lactation
Cochrane Systematic Reviews, 6-Aug-2012
Various pharmacologic and non-pharmacologic interventions have been used to suppress lactation after childbirth and relieve associated symptoms. Despite the large volume of literature on the subject, there is currently no universal guideline on the most a
- Treatments for symptomatic urinary tract infections during pregnancy
Cochrane Systematic Reviews, 5-Dec-2010
Urinary tract infections, including pyelonephritis, are serious complications that may lead to significant maternal and neonatal morbidity and mortality. There is a large number of drugs, and combination of them, available to treat urinary tract infection
- Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP)
Cochrane Systematic Reviews, 2-Apr-2020
This is an updated version of the original Cochrane Review, published in 2016, Issue 7.
- Treatments for toxoplasmosis in pregnancy
Cochrane Systematic Reviews, 10-Nov-2009
Toxoplasmosis is a widespread parasitic disease and usually causes no symptoms. However, infection of pregnant women may cause congenital infection, resulting potentially in mental retardation and blindness in the infant.
- Treatments for unruptured intracranial aneurysms
Cochrane Systematic Reviews, 10-May-2021
Unruptured intracranial aneurysms are relatively common lesions in the general population, with a prevalence of 3.2%, and are being diagnosed with greater frequency as non-invasive techniques for imaging of intracranial vessels have become increasingly av
- Trial of instrumental delivery in theatre versus immediate caesarean section for anticipated difficult assisted births
Cochrane Systematic Reviews, 22-Aug-2012
The majority of women have spontaneous vaginal births, but some women need assistance in the second stage with delivery of the baby, using either the obstetric forceps or vacuum extraction. Rates of instrumental vaginal delivery range from 5% to 20% of al
- Triclosan/copolymer containing toothpastes for oral health
Cochrane Systematic Reviews, 5-Dec-2013
Periodontal disease and dental caries are highly prevalent oral diseases that can lead to pain and discomfort, oral hygiene and aesthetic problems, and eventually tooth loss, all of which can be costly to treat and are a burden to healthcare systems. Tric
- Tricyclic and related drugs for nocturnal enuresis in children
Cochrane Systematic Reviews, 18-Jan-2016
Enuresis (bedwetting) affects up to 20% of five year-olds and 2% of adults. Although spontaneous remission often occurs, the social, emotional and psychological costs can be great. Tricyclics have been used to treat enuresis since the 1960s.
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Cochrane Systematic Reviews, 18-Sep-2014
Attention deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder of childhood onset, which may persist into adulthood. ADHD has a significant impact on a child's daily life, affecting relationships and academic performance. Its cor
- Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents
Cochrane Systematic Reviews, 16-Feb-2012
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders, ranging in severity and characterised by early onset of delay and deviance in the development of social interaction, and verbal and nonverbal communication. ASD is
- Tricyclic drugs for depression in children and adolescents
Cochrane Systematic Reviews, 13-Jun-2013
There is a need to identify effective and safe treatments for depression in children and adolescents. While tricyclic drugs are effective in treating depression in adults, individual studies involving children and adolescents have been equivocal. Prescrib
- Trifluoperazine for schizophrenia
Cochrane Systematic Reviews, 13-Apr-2010
Trifluoperazine is an inexpensive accessible 'high potency' antipsychotic drug, widely used to treat schizophrenia or related psychoses.
- Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
Cochrane Systematic Reviews, 25-Jun-2014
Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however, low-potency antipsychotic drugs are often perceived as less efficacious th
- Trifluoperazine versus placebo for schizophrenia
Cochrane Systematic Reviews, 7-Jan-2014
Trifluoperazine is a long-established high potency typical antipsychotic drug used in the treatment of schizophrenia and schizophrenia-like illnesses.
- Triflusal for preventing serious vascular events in people at high risk
Cochrane Systematic Reviews, 7-Oct-2008
Aspirin is the standard treatment for secondary prevention of stroke and other vascular events. Several studies suggest that triflusal may have a better safety profile.
- Trihexyphenidyl for dystonia in cerebral palsy
Cochrane Systematic Reviews, 15-May-2018
Cerebral palsy occurs in up to 2.1 of every 1000 live births and encompasses a range of motor problems and movement disorders. One commonly occurring movement disorder amongst those with cerebral palsy is dystonia: sustained or intermittent involuntary mu
- Trimetazidine for stable angina
Cochrane Systematic Reviews, 30-Sep-2008
Patients with stable angina not controlled by monotherapy with nitrates, beta blockers, or calcium channel blockers are often treated with combinations of these drugs. There may be adverse effects from, or contraindications to, the use of combinations. In
- Triphasic versus monophasic oral contraceptives for contraception
Cochrane Systematic Reviews, 10-Nov-2011
Side effects of oral contraceptive (OC) pills discourage adherence to and continuation of OC regimens. Strategies to decrease adverse effects led to the introduction of the triphasic OC in the 1980s. Whether triphasic OCs have higher accidental pregnancy
- Triptans for acute cluster headache
Cochrane Systematic Reviews, 16-Jul-2013
This is an updated version of the original Cochrane review published in Issue 4, 2010 (Law 2010). Cluster headache is an uncommon, severely painful, and disabling condition, with rapid onset. Validated treatment options are limited; first-line therapy inc
- Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome
Cochrane Systematic Reviews, 11-Aug-2013
Tripterygium wilfordii Hook F (TwHF), a traditional Chinese herbal medicine used as an immunosuppressive agent, has been prescribed in China for patients with primary nephrotic syndrome (NS) for more than two decades. Although patients with primary NS in
